Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

16.71 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 164
Open 16.71
Bid (Size) 15.07 (100)
Ask (Size) 18.38 (200)
Prev. Close 16.71
Today's Range 16.71 - 16.71
52wk Range 8.180 - 22.50
Shares Outstanding 47,147,781
Dividend Yield N/A

Performance

YTD
-7.5%
-7.5%
1 Month
-9.1%
-9.1%
3 Month
+36.4%
+36.4%
6 Month
+73.2%
+73.2%
1 Year
-7.2%
-7.2%

More News

Read More

Frequently Asked Questions

Is Nurix Therapeutics, Inc. - Common stock publicly traded?
Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Nurix Therapeutics, Inc. - Common stock trade on?
Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?
The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market
What is the current price of Nurix Therapeutics, Inc. - Common stock?
The current price of Nurix Therapeutics, Inc. - Common stock is 16.71
When was Nurix Therapeutics, Inc. - Common stock last traded?
The last trade of Nurix Therapeutics, Inc. - Common stock was at 02/09/26 04:00 PM ET
What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?
The market capitalization of Nurix Therapeutics, Inc. - Common stock is 787.84M
How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?
Nurix Therapeutics, Inc. - Common stock has 788M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.